Alexey Danilov

Associate Professor

  • 631 Citations
  • 16 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Alexey Danilov is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
Endoplasmic Reticulum Stress Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Ubiquitin-Activating Enzymes Medicine & Life Sciences
JNK Mitogen-Activated Protein Kinases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

  • 631 Citations
  • 16 h-Index
  • 50 Article
  • 3 Review article
  • 1 Letter
Ubiquitin-Activating Enzymes
Mantle-Cell Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Unfolded Protein Response

Relevance of Prognostic Factors in the Era of Targeted Therapies in CLL

Kittai, A. S., Lunning, M. & Danilov, A., Jan 1 2019, In : Current Hematologic Malignancy Reports.

Research output: Contribution to journalReview article

Phase III Clinical Trials
Chromosome Aberrations
3 Citations (Scopus)

Targeting ubiquitin-activating enzyme induces ER stress-mediated apoptosis in B-cell lymphoma cells

Best, S., Hashiguchi, T., Kittai, A., Bruss, N., Paiva, C., Okada, C., Liu, T., Berger, A. & Danilov, A., Jan 8 2019, In : Blood advances. 3, 1, p. 51-62 12 p.

Research output: Contribution to journalArticle

Ubiquitin-Activating Enzymes
Endoplasmic Reticulum Stress
Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma

The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells

Nechiporuk, T., Kurtz, S. E., Nikolova, O., Liu, T., Jones, C. L., D’alessandro, A., Culp-Hill, R., D’almeida, A., Joshi, S. K., Rosenberg, M., Tognon, C. E., Danilov, A., Druker, B., Chang, B., McWeeney, S. & Tyner, J., Jul 1 2019, In : Cancer discovery. 9, 7, p. 910-925 16 p.

Research output: Contribution to journalArticle

Myeloid Cells
Acute Myeloid Leukemia
Gene Silencing
Drug Combinations
Drug Resistance
8 Citations (Scopus)

Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib

Gordon, M. J., Churnetski, M., Alqahtani, H., Rivera, X., Kittai, A., Amrock, S. M., James, S., Hoff, S., Manda, S., Spurgeon, S., Choi, M., Cohen, J. B., Persky, D. & Danilov, A., Aug 1 2018, In : Cancer. 124, 15, p. 3192-3200 9 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
PCI 32765
Proportional Hazards Models
Disease-Free Survival